eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank

3/2024
vol. 16
 
Share:
Share:
Letter to the Editor

Letter to the Editor-in-Chief regarding “Adjuvant pulse-dose-rate brachytherapy for oral cavity and oropharynx carcinoma: Outcome and toxicity assessment of 66 patients”

Erkan Topkan
1
,
Efsun Somay
2
,
Ugur Selek
3

  1. Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey
  2. Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey
  3. Department of Radiation Oncology, School of Medicine, Koc University, Istanbul, Turkey
J Contemp Brachytherapy 2024; 16, 3: 171–172
Online publish date: 2024/06/28
Article file
Get citation
 
 
1. Renard S, Demogeot N, Bruand M et al. Adjuvant pulse-dose-rate brachytherapy for oral cavity and oropharynx carcinoma: Outcome and toxicity assessment of 66 patients. J Contemp Brachytherapy 2024; 16: 21-27.
2. Melzner WJ, Lotter M, Sauer R, Strnad V. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity? Radiother Oncol 2007; 82: 167-173.
3. Topkan E, Somay E, Yilmaz B et al. Risk factors for osteoradionecrosis of the jaw in the era of modern head and neck radiotherapy. Acta Sci Dent Sci 2023; 7: 68-81.
4. Kishino M, Shibuya H, Yoshimura R et al. A retrospective analysis of the use of brachytherapy in relation to early-stage squamous cell carcinoma of the oropharynx and its relationship to second primary respiratory and upper digestive tract cancers. Br J Radiol 2007; 80: 121-125.
5. García-Consuegra A, Gimeno Morales M, Cambeiro M et al. Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group. Radiother Oncol 2021; 154: 128-134.
6. Mazeron JJ, Crook JM, Marinello G et al. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation. Int J Radiat Oncol Biol Phys 1990; 19: 281-285.
7. Guinot JL, Santos M, Tortajada MI et al. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma. Brachytherapy 2010; 9: 227-234.
8. Santos M, Guinot JL, Tortajada M et al. Is perioperative brachytherapy effective in carcinoma of the tongue? J Contemp Brachytherapy 2022; 14: 23-28.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.